Element Capital Management’s Mustang Bio MBIO Stock Holding History

Element Capital Management’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-16	Closed	-$135K	–	939
2018 Q1	$135K	Buy	+16	New	+$136K	﹤0.01%	753

Other funds holding MBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Element Capital Management's MBIO Position: Q2 2018 in Review

Element Capital Management sold out of Mustang Bio (MBIO) in Q2 2018, closing a stake of 16 shares — an estimated $135K sold.

Element Capital Management first reported a position in MBIO in Q1 2018 and held it in 1 quarter. The position peaked at $135K in Q1 2018. 36 funds tracked by Wall St. Rank hold MBIO as of Q2 2018.

Element Capital Management reported no remaining Mustang Bio position as of Q2 2018 after selling out during the quarter.
Element Capital Management sold 16 Mustang Bio shares in Q2 2018, an estimated $135K.
Element Capital Management first reported a position in Mustang Bio in Q1 2018 and held it in 1 quarter.
Element Capital Management's Mustang Bio position peaked at $135K in Q1 2018.
36 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2018.

Based on Element Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.